Well, there went all my wife's work: Bayer CEO: "We did not develop this drug for Indians"

[lostincalifornia]

8. There is no doubt of the racism of the Bayer CEO. However, what is frustrating the pharmaceutical

companies is that their patents are being violated:

http://www.politico.com/story/2013/09/drug-companies-india-prime-minister-patents-97400.html

and even in India, this issue is not necessarily uniform:

http://www.reuters.com/article/2013/08/02/india-gsk-idUSL4N0G318920130802


On a different subject:

In addition, it should be noted that there are also major quality issues going on with some of the generics that Indian Pharmecuetical companies are producing:

"The U.S. Food and Drug Administration today notified Ranbaxy Laboratories, Ltd., that it is prohibited from manufacturing and distributing active pharmaceutical ingredients (APIs) from its facility in Toansa, India, for FDA-regulated drug products. The Toansa facility is now subject to certain terms of a consent decree of permanent injunction entered against Ranbaxy in January 2012.

The decree contains, among other things, provisions to ensure compliance with current good manufacturing practice (CGMP) requirements at Ranbaxy facilities in Paonta Sahib and Dewas, India, as well as provisions to address data integrity issues at those facilities. In September 2013, the FDA added Ranbaxy’s Mohali facility to the CGMP provisions of the decree.

Under the decree, the FDA has issued an order prohibiting Ranbaxy from:

distributing in the United States drugs manufactured using API from Toansa, including drugs made by Ranbaxy’s Ohm Laboratories facility in New Jersey;
manufacturing API at its Toansa facility for FDA-regulated drug products;
exporting API from Toansa to the United States for any purpose; and
providing API from Toansa to other companies, including other Ranbaxy facilities, making products for American consumers.
For more information, please visit: Toansa Facility

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm382736.htm

The CEO from Bayer should be fired for his comments.

However, the underlying issue needs to be debated, and is now lost with the CEOs racist rant.